GAVILYTE-N
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43386-050 -
Package NDC
43386-050-19 -
Application number
ANDA090019 -
SPL ID
3839c7fd-e7c4-45c6-ae02-0302b40046b0 -
SPL set ID
27195187-75a3-431f-90d9-84da1b94e849 -
UNII
G2M7P15E5P -
UNII
451W47IQ8X -
UNII
8MDF5V39QO -
UNII
660YQ98I10 -
RxCUI
801054 -
RxCUI
979099
What the source publishes
- Labeler
- Lupin Pharmaceuticals,Inc.
- Active ingredients
- polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
- Form
- POWDER, FOR SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- GAVILYTE-N
- polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
- POLYETHYLENE GLYCOL 3350
- SODIUM CHLORIDE
- SODIUM BICARBONATE
- POTASSIUM CHLORIDE
Complete source data
{
"name": "GAVILYTE-N",
"splId": "3839c7fd-e7c4-45c6-ae02-0302b40046b0",
"labels": [
{
"setId": "27195187-75a3-431f-90d9-84da1b94e849",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27195187-75a3-431f-90d9-84da1b94e849",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=27195187-75a3-431f-90d9-84da1b94e849"
}
],
"routes": [
"ORAL"
],
"labeler": "Lupin Pharmaceuticals,Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "438.4 g in 1 BOTTLE (43386-050-19)",
"package_ndc": "43386-050-19",
"identifierStatus": "well-formed",
"marketing_start_date": "20090528"
}
],
"productId": "43386-050_3839c7fd-e7c4-45c6-ae02-0302b40046b0",
"useDomain": "unknown",
"dosageForm": "POWDER, FOR SOLUTION",
"productNdc": "43386-050",
"deaSchedule": null,
"genericName": "polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POLYETHYLENE GLYCOL 3350",
"strength": "420 g/438.4g"
},
{
"name": "SODIUM CHLORIDE",
"strength": "11.2 g/438.4g"
},
{
"name": "SODIUM BICARBONATE",
"strength": "5.72 g/438.4g"
},
{
"name": "POTASSIUM CHLORIDE",
"strength": "1.48 g/438.4g"
}
],
"applicationNumber": "ANDA090019",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20090528",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000010288",
"N0000175811",
"N0000009871"
],
"unii": [
"G2M7P15E5P",
"451W47IQ8X",
"8MDF5V39QO",
"660YQ98I10"
],
"rxcui": [
"801054",
"979099"
],
"spl_set_id": [
"27195187-75a3-431f-90d9-84da1b94e849"
],
"pharm_class_pe": [
"Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"
],
"pharm_class_epc": [
"Osmotic Laxative [EPC]"
],
"pharm_class_moa": [
"Osmotic Activity [MoA]"
],
"manufacturer_name": [
"Lupin Pharmaceuticals,Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43386-050_3839c7fd-e7c4-45c6-ae02-0302b40046b0"